SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-006766
Filing Date
2020-02-26
Accepted
2020-02-26 16:02:33
Documents
72
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vktx-10k_20191231.htm 10-K 2512649
2 EX-4.5 vktx-ex45_173.htm EX-4.5 58282
3 EX-23.1 vktx-ex231_7.htm EX-23.1 3123
4 EX-31.1 vktx-ex311_6.htm EX-31.1 20330
5 EX-31.2 vktx-ex312_8.htm EX-31.2 20342
6 EX-32.1 vktx-ex321_11.htm EX-32.1 12703
7 GRAPHIC gyinrebcjkit000001.jpg GRAPHIC 14649
  Complete submission text file 0001564590-20-006766.txt   9031960

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vktx-20191231.xml EX-101.INS 1934244
9 XBRL TAXONOMY EXTENSION SCHEMA vktx-20191231.xsd EX-101.SCH 66639
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20191231_cal.xml EX-101.CAL 62117
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20191231_def.xml EX-101.DEF 223040
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20191231_lab.xml EX-101.LAB 516413
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20191231_pre.xml EX-101.PRE 400943
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37355 | Film No.: 20655596
SIC: 2834 Pharmaceutical Preparations